Skip to main content

Thermo Fisher Scientific Inc.

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 22, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

Pipette Calibration Market to Hit $834.8M by 2031 as Transcat Drives M&A

Pipette Calibration Market to Hit $834.8M by 2031 as Transcat Drives M&A

Delray Beach, Fla. – September 17, 2026 -- The global pipette calibration services market is projected to more than double to USD 834.8 million by 2031 from USD 383.2 million in 2026, a 16.9% compound annual growth rate, according to MarketsandMarkets.

North America controls half of global demand as regulatory pressure mounts

North America held a 50.6% share of the pipette calibration services market in 2025, underpinned by dense pharmaceutical and biotechnology infrastructure, federal biomedical research funding, and strict laboratory equipment qualification requirements. Thermo Fisher Scientific, Eppendorf, and Sartorius operate significant service footprints across the region, supporting clinical labs, academic institutions, and drug manufacturers requiring traceable measurement accuracy.